ADHD and Intelligence polygenic scores and their associations with dimensional developmental characteristics within a paediatric transdiagnostic cohort - Santangelo, Andrea M.; Ohlei, Olena; Mareva, Silvana; Brkic, Diandra; CALM team; Bertram, Lars; Holmes, Joni; Astle, Duncan; Baker, Kate (medRxiv, 2023)
Background Common genetic variants make a significant contribution to dimensional neurodevelopmental characteristics such as ADHD symptoms and cognitive abilities. The relevance and structure of these associations within a transdiagnostic sample referred for difficulties in cognition, attention and learning has not been demonstrated.Methods Polygenic scores (PGS) derived from recent genome-wide association study (GWAS) data on ADHD and Intelligence were calculated from genome-wide genotyping data for 524 children and young people referred to the Centre for Attention, Learning and Memory (CALM). PGS-trait associations were tested via linear regression analyses, for a range of neurodevelopmental characteristics, and factor scores from a hierarchical model of psychopathology. Associations were explored with and without co-varying for socio-economic status (SES).Results We found the expected associations within the sample between ADHD-PGS and ADHD symptom dimensions, and between Intelligence-PGS and IQ test scores. ADHD-PGS were also associated with broader externalising behaviours and with verbal intelligence, but the latter only if SES was not included as a covariate. Examining associations with hierarchical factor scores, we found a relationship between ADHD-PGS and a general mental health factor, externalising factor, and social maladjustment factor, however these associations did not survive co-variation for SES and correction for multiple comparisons. The Intelligence-PGS showed significant associations only with verbal and non-verbal cognitive skills, which were independent of SES; and no links were observed with ADHD traits or mental health factor scores.Conclusion Our finding suggest that PGS derived from previous GWAS have research utility for paediatric transdiagnostic samples, showing both specific and general associations with neurodevelopmental traits. Future studies investigating PGS and cognitive and neural correlates within this cohort, as well as gene-by-environment interactions, may contribute to our understanding of developmental pathways and risk-resilience mechanisms in child mental health.Key pointsCommon polygenic variation, quantified by PolyGenic Scores (PGS), contributes to dimensional neurodevelopmental characteristics. However, PGS relevance has not been demonstrated in a paediatric transdiagnostic sample.We studied the associations between neurodevelopmental dimensions and ADHD PGS or Intelligence PGS, within a cohort of children referred for difficulties in cognition, attention and/or learning.ADHD-PGS contributed to ADHD symptoms, as well as to externalizing behaviours, verbal intelligence, and hierarchical factors of mental health, with some of these associations being influenced by socioeconomic status (SES).Intelligence-PGS in contrast, showed associations only with cognitive skills (verbal and non-verbal IQ), which were independent of SES; and did not link with ADHD traits or mental health factor scores.Further research building on these findings will contribute to our understanding of developmental pathways and risk-resilience mechanisms in child mental health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMedical Research Council (G116768) Isaac Newton Trust Wellcome Trust ISSF University of Cambridge Joint Research Grants scheme National Institute for Health and Care Research Cambridge Biomedical Research Centre (NIHR203312) and the NIHR Applied Research Collaboration East of England EU Horizon2020 (Grant agreement number: 732592)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All procedures complied with the ethical standards of the national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All procedures involving human participants were approved by the National Health Service, Health Research Authority NRES Committee East of England (REC: 13/EE/0157, IRAS 127675).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesBehavioural and cognitive data is available online through the CALM Managed Open Access repository: https://portal.ide-cam.org.uk/overview/1158. Genetic data is available via collaboration with CALM. https://portal.ide-cam.org.uk/overview/1158